Evidence map›Paper›PMID 37367816›Full record

ReviewMembranes2023

Challenges and Solutions for Global Water Scarcity.

Hilla Shemer, Shlomo Wald, Raphael Semiat

Abstract readReview
In one paragraph

Review in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. AnthropogenicMicroorganisms · 2025
    Article
  18. Review
  19. Article
  20. EnhancingCatalysts (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hilla ShemerThe Wolfson Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.ORCID 0000-0001-7588-9690
Shlomo WaldWald Industries, Tor HaAviv 1, Rehovot 7632101, Israel.
Raphael SemiatThe Wolfson Department of Chemical Engineering, Technion-Israel Institute of Technology, Haifa 3200003, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Climate change, global population growth, and rising standards of living have put immense strain on natural resources, resulting in the unsecured availability of water as an existential resource. Access to high-quality drinking water is crucial for daily life, food production, industry, and nature. However, the demand for freshwater resources exceeds the available supply, making it essential to utilize all alternative water resources such as the desalination of brackish water, seawater, and wastewater. Reverse osmosis desalination is a highly efficient method to increase water supplies and make clean, affordable water accessible to millions of people. However, to ensure universal access to water, various measures need to be implemented, including centralized governance, educational campaigns, improvements in water catchment and harvesting technologies, infrastructure development, irrigation and agricultural practices, pollution control, investments in novel water technologies, and transboundary water cooperation. This paper provides a comprehensive overview of measures for utilizing alternative water sources, with particular emphasis on seawater desalination and wastewater reclamation techniques. In particular, membrane-based technologies are critically reviewed, with a focus on their energy consumption, costs, and environmental impacts.

Indexed as

desalinationenergy consumptionenvironmental impactsreverse osmosiswastewater reclamation

Identifiers

PMID37367816
PMCPMC10300917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.